ADPT

Adaptive Biotechnologies
ADPT

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.10B
EV
$1.06B
Shares Outstanding
148.58M
Beta
1.73

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$9.71
P/E 2025E
-
P/Revenue 2025E
5.16x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Adaptive Biotechnologies Corporation

gainify
ADPT

Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biol...

Sector

Healthcare

Industry

Biotechnology

CEO

Robins, Chad

Employees

619

IPO Date

2019-06-27

Headquarters

1165 Eastlake Avenue East, Seattle, Washington, 98109, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved